FDA Drug recall D-1446-2014
Taztia XT (Diltiazem HCl) Capsules, 120 mg, Rx, Packaged and labeled as Thiamine
- FDA Drug
- Class I
- terminated
- Published 2014-07-30
On 2014-07-30 the FDA classified a Class I recall of Taztia XT (Diltiazem HCl) Capsules, 120 mg, Rx, Packaged and labeled as Thiamine by Shamrock Medical Solutions Group, citing labeling: Label Mix Up; packages labeled as Thiamine actually contain Diltiazem Capsules.
Read the official FDA Drug notice
| Agency | FDA Drug |
|---|---|
| Recall number | D-1446-2014 |
| Classification | Class I |
| Status | terminated |
| Initiated | 2011-09-27 |
| Published | 2014-07-30 |
| Last updated | 2026-09-13 11:51 UTC |
| Company | Shamrock Medical Solutions Group |
| Distribution | CO, MA, OH, TX, WY |
Product
Taztia XT (Diltiazem HCl) Capsules, 120 mg, Rx, Packaged and labeled as Thiamine. Re-Packaged By: Shamrock Medical Solutions, Lewis Center, Ohio, Mfg: Watson Laboratories, Corona, CA NDC 62037-0696-90
Reason
Labeling: Label Mix Up; packages labeled as Thiamine actually contain Diltiazem Capsules
Identifiers
| code_info | Use By: 5/31/2013, Lot: 0021OC, NDC 62037-0696-90 |
|---|
Status history
No status changes recorded since RecallRadar first saw this recall on 2026-09-13 11:51 UTC. Current status: terminated.
Source
Official record: https://api.fda.gov/drug/enforcement.json?search=recall_number:%22D-1446-2014%22
RecallRadar indexes public recall notices from the FDA, USDA FSIS, and CPSC. The official agency notice is the authoritative source. Always confirm details at the linked source before acting.